Article -> Article Details
| Title | Oral Mucositis Market Players, Growth Opportunities and Forecast to 2032 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Oral Mucositis Market, Oral Mucositis Market Size, Oral Mucositis Market Industry, Global Oral Mucositis Market, Oral Mucositis Market Research, Oral Mucositis Market Analysis, |
| Owner | Vaibhav |
| Description | |
|
The oral
mucositis market is expected to reach USD 0.98
Billion by 2032 at 7.80% CAGR during the forecast period 2023-2032 Prevalence of
chronic disease such as cancer has multifarious effects on the human body. One
such is oral mucositis where individuals suffer from painful lesions of the
mucous membranes. This can be seen as a side-effect of the chemotherapy, and it is proportional to the growth of the chemotherapy dose.
The disease can adversely affect an individual’s nutritional habits as it
prevents the patient from chewing solid foods and even at times, from
swallowing it. Among chief drivers, recently patented drugs for oral mucositis
are playing significant roles. Furthermore, several investments in research and
development are also ensuring considerable market growth. However, most
of the medicines are costly, and some await clinical trial and license. This
could deter the expected market growth during the forecast period. Market Segmentation The global oral mucositis market can be segmented by cause
and end-users. Based on cause, the oral mucositis market includes oral
mucositis caused by mucositis chemotherapy, oral mucositis caused by radiotherapy,
and hematopoietic stem cell transplantation. Based on end-users, the oral mucositis market includes
hospitals, dental clinics, oncology hospitals, and research institutes. Major Key
Players: Some of Oral Mucositis Market Players are Izun Pharmaceutical Ltd
(US), Shoreline Pharmaceuticals Inc. (USA), Himalaya (India), AMAG
Pharmaceuticals Inc. (USA), Kinnear Pharmaceuticals (US), Celleutix Corporation
(USA), Soligenix Inc. (US), Oragenics (US), and others. Regional
Analysis Based on the global coverage, the
oral mucositis market can be analyzed keeping up with the following regions:
the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa
(MEA). By gaining tailwind from the
presence of major brands with FDA approved drugs and superior infrastructure,
the Americas are driving the market forward. Furthermore, massive investment in
the healthcare sector, coupled with well-planned reimbursement policies, is
giving the market further thrust. Europe is enjoying similar kind
of benefits and is spending much on research and development to gain the upper
hand in its battle against oral mucositis. Meanwhile, the APAC is registering
substantial growth owing to its impressive revamping of the healthcare sector.
Better infrastructure in emerging economies such as India and China can prove
beneficial for the market. However, the MEA market is lagging behind. Its poor
infrastructure has put a leash on the regional market growth. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |